| KIORA PHARMACEUTICALS |
| USA |
| Gesundheit |
| US49721T5074 / A40EG5 |
| 7EY (Frankfurt) / KPRX (NASDAQ) |
| FRA:7EY, ETR:7EY, 7EY:GR, NASDAQ:KPRX |
| - |
| https://kiorapharma.com/ |
| - |
| 6.59 Mio. EUR |
| -7.86 Mio. EUR |
| - |
| -8.09 Mio. EUR |
| -9.37 Mio. EUR |
| -2.41 EUR |
| 0.32 Mio. EUR |
| 7.52 Mio. EUR |
| -8.61 Mio. EUR |
| 4.71 |
| -100% |
| -401.42% |
| - |
| - |
| - |
| - |
| KIORA PHARMACEUTICALS, KIORA PHARMA, KIORA PHARMACEUTICAL |
| 01.04.26 |
|